Bristol-Myers Squibb S.A.R.L.

Patent No. 7,615,556 Issued on Nov. 10, Assigned to Bristol-Myers Squibb for Piperazinyl Derivative (New Jersey Inventors)
US Fed News Service, Including US State News; 11/11/2009; 422 words; ...16 -- Cullen L. Cavallaro of...were issued U.S. Patent No...been assigned to Bristol-Myers Squibb Co., Princeton...released by the U.S. Patent &...wherein m, T, W, R, R, R, Rand Rare...f=G&l=50&co1...

Patent No. 7,612,069 Issued on Nov. 3, Assigned to Bristol-Myers Squibb for Acyl Guanidines (Connecticut Inventors)
US Fed News Service, Including US State News; 11/4/2009; 465 words; ...were issued U.S. Patent No...been assigned to Bristol-Myers Squibb Co., Princeton...released by the U.S. Patent &...of Alzheimer's Disease (AD...html&r=1&f=G&l=50&co1...

Patent No. 7,608,408 Issued on Oct. 27, Assigned to Bristol-Myers Squibb for Vitro Cell-Based Method (Connecticut, New Jersey Inventors)
US Fed News Service, Including US State News; 10/29/2009; 449 words; ...inventors were issued U.S. Patent No. 7,608...has been assigned to Bristol-Myers Squibb Co., Princeton, N...abstract released by the U.S. Patent & Trademark...bool.html&r=1&f=G&l=50&co1=AND...

ZymoGenetics Initiates Phase 2 Clinical Trial of PEG-Interferon lambda in Hepatitis C with Bristol-Myers Squibb.
Business Wire; 10/27/2009; 1510 words; ...ZymoGenetics from Bristol-Myers Squibb Company (NYSE...said Eleanor L. Ramos, M...to PEGASYS([R]). All patients...The company's strategy is to...RECOTHROM([R]) Thrombin...the company's public filings...

Patent No. 7,605,160 Issued on Oct. 20, Assigned to Bristol-Myers Squibb for Pyrrolotriazine Kinase Inhibitors (Pennsylvania, New Jersey Inventors)
US Fed News Service, Including US State News; 10/24/2009; 402 words; ...inventors were issued U.S. Patent No. 7,605...has been assigned to Bristol-Myers Squibb Co., Princeton, N...abstract released by the U.S. Patent & Trademark...bool.html&r=1&f=G&l=50&co1=AND...